Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [913]
News [2612]
Articles [111]
Editorials [3]
Conferences [85]
elearning [27]
FDA approves ensartinib for ALK-positive locally advanced or metastatic non-small cell lung cancer
FDA approves ensartinib for ALK-positive locally advanced or metastatic non-small cell lung cancer
FDA approves ensartinib for ALK-positive locally advanced or metastatic non-small cell lung cancer
FDA approves ensartinib for ALK-positive locally advanced or metastatic non-small cell lung cancer
Researchers make economic case for a national lung cancer screening programme in Australia
Researchers make economic case for a national lung cancer screening programme in Australia
In five cancer types, prevention and screening have been major contributors to saving lives in the US
In five cancer types, prevention and screening have been major contributors to saving lives in the US
Five new papers highlight cancer inequities, challenges and opportunities in South Asia
Five new papers highlight cancer inequities, challenges and opportunities in South Asia
Pharmacokinetics comparison of aumolertinib, osimertinib, gefitinib and their major metabolites in mouse model and NSCLC patients
Pharmacokinetics comparison of aumolertinib, osimertinib, gefitinib and their major metabolites in mouse model and...
Diabetes drug appears to fight lung cancer — But only in overweight or obese patients
Diabetes drug appears to fight lung cancer — But only in overweight or obese patients
Amivantamab in combination with lazertinib for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer
Amivantamab in combination with lazertinib for the first-line treatment of patients with EGFR-mutated advanced non...
AI analysis of PET/CT images can predict side effects of immunotherapy in lung cancer
AI analysis of PET/CT images can predict side effects of immunotherapy in lung cancer
Combination approach shows promise for treating rare, aggressive cancers
Combination approach shows promise for treating rare, aggressive cancers

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation